Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nano Interface Technology is a biotechnology company specializing in the development of nanotechnology-based drug delivery systems and surface modifications for medical applications. The company's core technology involves the fabrication of nano-needle and nano-pillar arrays designed for efficient transdermal and intracellular delivery of therapeutics, including vaccines, proteins, and genetic material. By leveraging advanced nanofabrication techniques, the company aims to enhance the bioavailability and efficacy of drugs while minimizing invasive procedures. Their research also extends to improving the biocompatibility of medical implants through specialized surface coatings. The company has historically been supported by numerous federal research grants to advance its proprietary delivery platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano Interface Technology.